ID26485A - Komposisi paroksetina - Google Patents

Komposisi paroksetina

Info

Publication number
ID26485A
ID26485A IDW20001883A ID20001883A ID26485A ID 26485 A ID26485 A ID 26485A ID W20001883 A IDW20001883 A ID W20001883A ID 20001883 A ID20001883 A ID 20001883A ID 26485 A ID26485 A ID 26485A
Authority
ID
Indonesia
Prior art keywords
paroxoxine
composition
paroxoxine composition
Prior art date
Application number
IDW20001883A
Other languages
English (en)
Inventor
Craig Andrew Simon
Ward Neal
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID26485A publication Critical patent/ID26485A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IDW20001883A 1998-03-24 1999-03-24 Komposisi paroksetina ID26485A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations

Publications (1)

Publication Number Publication Date
ID26485A true ID26485A (id) 2001-01-11

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001883A ID26485A (id) 1998-03-24 1999-03-24 Komposisi paroksetina

Country Status (20)

Country Link
EP (1) EP1063993A1 (id)
JP (1) JP2002507569A (id)
CN (1) CN1125639C (id)
AP (1) AP2000001914A0 (id)
AU (1) AU754765B2 (id)
BG (1) BG104865A (id)
BR (1) BR9908991A (id)
CA (1) CA2324612A1 (id)
EA (1) EA003393B1 (id)
GB (1) GB9806312D0 (id)
HU (1) HUP0101326A3 (id)
ID (1) ID26485A (id)
IL (1) IL138478A0 (id)
NO (1) NO313404B1 (id)
NZ (1) NZ506893A (id)
PL (1) PL343095A1 (id)
SK (1) SK14102000A3 (id)
TR (1) TR200002750T2 (id)
WO (1) WO1999048499A1 (id)
ZA (1) ZA200005697B (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
CA2531097C (en) * 2003-07-02 2012-10-09 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
CN1294512A (zh) 2001-05-09
NO313404B1 (no) 2002-09-30
ZA200005697B (en) 2001-10-02
BR9908991A (pt) 2000-12-12
TR200002750T2 (tr) 2000-12-21
HUP0101326A2 (hu) 2002-05-29
EA200000977A1 (ru) 2001-02-26
PL343095A1 (en) 2001-07-30
EA003393B1 (ru) 2003-04-24
WO1999048499A1 (en) 1999-09-30
AU754765B2 (en) 2002-11-21
IL138478A0 (en) 2001-10-31
CN1125639C (zh) 2003-10-29
AU3045199A (en) 1999-10-18
SK14102000A3 (sk) 2001-03-12
GB9806312D0 (en) 1998-05-20
JP2002507569A (ja) 2002-03-12
NO20004740D0 (no) 2000-09-22
HUP0101326A3 (en) 2002-06-28
CA2324612A1 (en) 1999-09-30
BG104865A (en) 2001-05-31
AP2000001914A0 (en) 2000-09-30
EP1063993A1 (en) 2001-01-03
NO20004740L (no) 2000-10-03
NZ506893A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
ID29430A (id) Komposisi herbisida
ID26926A (id) Komposisi shampo pembentuk mode
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
FI981011L (fi) Uudet koostumukset
ATE469550T1 (de) Antiparasitäre zusammensetzungen
DE69919953D1 (de) Funktionelle zusammensetzungen
ID25508A (id) Komposisi dematologis
DE69927758D1 (de) Imidosilan-Zusammensetzungen
ID23458A (id) Bentuk sediaan nefazodon
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
ID23761A (id) Trisiklik tersubstitusi
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
ID23250A (id) Komposisi paroksetin
ID21906A (id) Komposisi adesif
ID23219A (id) Trisiklik tersubstitusi
DE69809804D1 (de) Notlaufgeländereifen
NO996073D0 (no) Hockeykoelle
DE59807217D1 (de) Nadellager
ID26295A (id) Komposisi keras-ultraviolet
NO20005483L (no) Ny sammensetning
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals